Search research articles
Contact Us
Filters
Showing results (31-40 of 55) with videos related to
Page
of 6
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1985
Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog
E J Sybertz, R W Watkins, T Baum, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Effects of the antihypertensive dilevalol on large artery compliance in anesthetized dogs
R W Watkins, E J Sybertz, A Antonellis, et al.
Journal of Ocular Pharmacology
|
January 1, 1988
Systemic effects resulting from topical ocular administration of SCH 33861, a novel ACE inhibitor ocular hypotensive agent
R W Watkins, T Baum, R P Tedesco, et al.
Journal of Ocular Pharmacology
|
January 1, 1985
Comparative effects of SCH 19927 and timolol on intraocular pressure of conscious rabbits and relative systemic beta-blockade resulting from topical administration
R W Watkins, D P Cummins, G Vander Vliet, et al.
Journal of Chiropractic Humanities
|
November 29, 2014
Improving Our Nation's Health Care System: Inclusion of Chiropractic in Patient-Centered Medical Homes and Accountable Care Organizations
William C Meeker, R W Watkins, Karl C Kranz, et al.
Journal of the South Carolina Medical Association (1975)
|
November 1, 1977
Neoplasms of the small intestine
R W Watkins, J E Bottsford, A Woods, et al.
Life Sciences
|
January 1, 1993
Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats
S Vemulapalli, R W Watkins, A Brown, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
September 1, 1993
Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats
M S Chintala, P J Chiu, S Vemulapalli, et al.
Metabolism: Clinical and Experimental
|
October 5, 2001
The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs
H R Davis, K K Pula, K B Alton, et al.
Progress in Clinical and Biological Research
|
January 1, 1986
AGEPC, a vasodilator phospholipid with profound circulatory actions
E J Sybertz, R W Watkins, S Vemulapalli, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 55) with videos related to
Sort By:
Page
of 6
The Journal of Pharmacology and Experimental Therapeutics
|
January 1, 1985
Cardiac, coronary and peripheral vascular effects of acetyl glyceryl ether phosphoryl choline in the anesthetized dog
E J Sybertz, R W Watkins, T Baum, et al.
Journal of Cardiovascular Pharmacology
|
January 1, 1987
Effects of the antihypertensive dilevalol on large artery compliance in anesthetized dogs
R W Watkins, E J Sybertz, A Antonellis, et al.
Journal of Ocular Pharmacology
|
January 1, 1988
Systemic effects resulting from topical ocular administration of SCH 33861, a novel ACE inhibitor ocular hypotensive agent
R W Watkins, T Baum, R P Tedesco, et al.
Journal of Ocular Pharmacology
|
January 1, 1985
Comparative effects of SCH 19927 and timolol on intraocular pressure of conscious rabbits and relative systemic beta-blockade resulting from topical administration
R W Watkins, D P Cummins, G Vander Vliet, et al.
Journal of Chiropractic Humanities
|
November 29, 2014
Improving Our Nation's Health Care System: Inclusion of Chiropractic in Patient-Centered Medical Homes and Accountable Care Organizations
William C Meeker, R W Watkins, Karl C Kranz, et al.
Journal of the South Carolina Medical Association (1975)
|
November 1, 1977
Neoplasms of the small intestine
R W Watkins, J E Bottsford, A Woods, et al.
Life Sciences
|
January 1, 1993
Disparate effects of phosphoramidon on blood pressure in SHR and DOCA-salt hypertensive rats
S Vemulapalli, R W Watkins, A Brown, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
September 1, 1993
Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats
M S Chintala, P J Chiu, S Vemulapalli, et al.
Metabolism: Clinical and Experimental
|
October 5, 2001
The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors in dogs
H R Davis, K K Pula, K B Alton, et al.
Progress in Clinical and Biological Research
|
January 1, 1986
AGEPC, a vasodilator phospholipid with profound circulatory actions
E J Sybertz, R W Watkins, S Vemulapalli, et al.
Page
of 6